Skip to main content
CVS GROUP PLC logo

CVS GROUP PLC — Investor Relations & Filings

Ticker · CVSG ISIN · GB00B2863827 LEI · 213800J41XDQ2NX48O05 IL Professional, scientific and technical activities
Open in API
Filings indexed 790 across all filing types
Latest filing 2023-03-31 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL CVSG

About CVS GROUP PLC

https://www.cvsuk.com/

CVS Group PLC is an integrated veterinary services provider. Established in 1999, the company operates a large network of veterinary practices, offering a comprehensive range of clinical services for animals. The group's operations are vertically integrated, encompassing not only primary care and specialist referral practices but also diagnostic laboratories, pet crematoria, and an online retail business. The company focuses on delivering high-quality clinical care and support services across its divisions, with a stated purpose of providing the best possible care to animals.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS, the news service of the London Stock Exchange' at the end. The content details the exercise of employee stock options (SAYE Plan), the resulting issuance of new ordinary shares, and the resulting total number of voting rights (71,388,944). This type of announcement, which updates the market on changes to the total share capital and voting rights, is a mandatory regulatory disclosure. While it relates to share capital changes (SHA), the primary function here is a formal regulatory notification disseminated via the RNS system, often categorized as a general regulatory filing or a specific notification related to share structure changes. Given the context of updating the total voting rights denominator for shareholders (FCA Disclosure Guidance), it strongly aligns with a general regulatory announcement disseminated through the RNS platform. Since it is not a full report (like 10-K or IR) and is a specific, short regulatory update, RNS (Regulatory Filings) is the most appropriate general classification, although SHA is also relevant. However, the presence of the RNS header and footer strongly suggests the 'RNS' category for general regulatory updates that aren't one of the other specific report types.
2023-03-31 English
Exercise of SAYE Options, PDMR Dealing and TVR
Director's Dealing Classification · 1% confidence The document is clearly identified by the 'RNS Number' header and contains information about the exercise of SAYE options by a Director (Ben Jacklin, COO) and the resulting change in total voting rights. This type of filing, which reports personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content mandates the DIRS classification over the general RNS fallback. It is not a general regulatory announcement (RNS) because it is highly specific to insider trading disclosure requirements under UK Market Abuse Regulation.
2023-03-10 English
Exercise of Options and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document begins with 'RNS Number : 1986R' and concludes with standard RNS boilerplate text, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content specifically details the 'Exercise of Options' under an employee share scheme (SAYE Plan), resulting in the issuance of new ordinary shares and an update to the 'total number of voting rights'. This action directly impacts the company's share capital and total voting rights, which is a mandatory disclosure under transparency rules. While it relates to share capital changes (SHA), the primary function here is a mandatory regulatory notification of a change in total voting rights, often categorized under general regulatory filings or specific share transaction reports. Given the context of an RNS release detailing a change in total voting rights denominator for shareholder notification purposes, the most appropriate general category for this type of mandatory, short regulatory update that isn't a full financial report or a specific insider trade is 'Regulatory Filings' (RNS), as it serves as a general regulatory announcement. Alternatively, since it explicitly details the issuance of new shares and the resulting total share capital, 'Share Issue/Capital Change' (SHA) is also highly relevant. However, RNS filings are often used for these specific, short updates required by listing rules. Given the strong RNS branding and the nature of the disclosure (Total Voting Rights update), RNS is a safe classification, but SHA captures the core corporate action. Since the document is short and is a direct notification of a change in the total number of shares/voting rights, SHA is more specific than the general RNS fallback. I will classify it as SHA as it is a direct report of a capital change resulting from option exercises.
2023-02-28 English
Interim Results
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim results' announcement for CVS Group plc for the six months ended 31 December 2022. It contains detailed financial highlights, operational updates, and management commentary. While it is titled 'Interim report', it is presented in the format of an RNS (Regulatory News Service) announcement, which is the standard way UK-listed companies release their interim financial results to the market. According to the classification rules, this document provides substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-02-24 English
Exercise of Options and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header 'RNS Number' and contains information about the exercise of employee stock options (SAYE Plans) resulting in the issuance of new ordinary shares and a change in the total voting rights (71,380,400). This type of announcement, detailing changes in the total number of shares and voting rights, is a mandatory regulatory disclosure. Since it is a specific regulatory announcement that doesn't fit into categories like Director's Dealing (DIRS), Share Issue (SHA), or Transaction in Own Shares (POS) which usually relate to buybacks or specific capital changes, and it is clearly an RNS release from the London Stock Exchange, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard market disclosure. However, upon reviewing the definitions, the content specifically relates to changes in the total number of shares and voting rights due to option exercises. This is a form of capital change notification. While 'SHA' (Share Issue/Capital Change) is a possibility, the context is a routine notification of share issuance following option vesting, often reported via RNS. Given the structure and the explicit mention of RNS and FCA rules regarding voting rights denominator, RNS is a strong candidate. Let's re-evaluate against SHA. SHA is for 'new share issues, stock splits, or other capital changes'. This is a new share issue. Since the document explicitly states the issuance of 108,429 new Ordinary Shares and calculates the new total voting rights, SHA is more specific than the general RNS fallback. I will classify it as SHA.
2023-02-02 English
Half year Trading Update
Earnings Release Classification · 1% confidence The document is a 'Half year Trading Update' issued by CVS Group plc. It provides key financial highlights (revenue, LFL sales, EBITDA margin, capex, and net debt) for the six months ended 31 December 2022. While it mentions that interim results will be announced later, the document itself contains substantive financial data and performance metrics for the period, fitting the definition of an Earnings Release (ER) as it serves as the initial announcement of periodic financial results. H1 2023
2023-01-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.